≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Nontoxic single thyroid nodule

DOID EFO Endpoint Browser PheWeb

E4_GOITRENOD

nodular goiter: Goiter characterized by discrete tissue mass(es) that may or may not produce thyroid hormones.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E04.1
  • Hospital discharge: ICD-9 — 2410|2462
  • Cause of death: ICD-10 — E04.1
  • Cause of death: ICD-9 — 2410|2462

2 out of 7 registries used, show all original rules.

2866

4. Check minimum number of events

None

2866

5. Include endpoints

None

2866

6. Filter based on genotype QC (FinnGen only)

2866

Control definitions (FinnGen only)

Control exclude
E4_THYROID

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E04
Name in latin
Struma atoxica uninodularis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 17821 14391 3351
Only index persons 16839 13735 3104
Unadjusted period prevalence (%)
Whole population 0.35 0.41 0.09
Only index persons 0.43 0.50 0.12
Median age at first event (years)
Whole population 51.50 50.54 55.53
Only index persons 50.93 50.05 54.82

-FinnGen-

Key figures

All Female Male
Number of individuals 2866 2312 554
Unadjusted period prevalence (%) 0.68 0.79 0.24
Median age at first event (years) 51.34 49.48 59.10

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2583
Matched controls
25830
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
106.5
323.0
427
48
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
223.0
323.0
639
38
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
9098.8
323.0
2220
16
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
360.7
323.0
816
33
H03AA01
ATC
levothyroxine sodium; systemic
66.9
323.0
1098
282
104
Kela drug reimbursment
Thyroid insufficiency
365.0
323.0
399
13
2410A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic uninodular goitre
+∞
309.7
291
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
69.8
306.2
351
58
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
63.3
280.8
327
59
2504
FHL
Unilateral resection or enucleation
159.8
235.2
246
17
EP1AE
NOMESCO Finland
Neck ultrasound examination
10.8
219.3
449
494
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
+∞
197.5
187
*
BAA60
NOMESCO Finland
Total thyroidectomy
411.3
193.6
192
5
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
42.1
189.5
238
62
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
56.3
182.6
217
42
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
406.1
155.0
154
*
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
164.7
148.2
155
10
E03
ICD-10 Finland
Other hypothyroidism
63.0
146.6
171
29
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
457.0
132.3
131
*
E03.89
ICD-10 Finland
Other specified hypothyroidism
115.9
122.3
132
12
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
51.8
122.0
147
30
BAA20
NOMESCO Finland
Unilateral partial excision of thyroid gland
213.2
118.7
122
6
T86
ICPC
Hypothyroidism/myxoedema
36.7
97.7
126
36
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
127.2
91.6
98
8
2462A
ICD-9 Finland
Other disorders of thyroid, Cyst of thyroid
+∞
83.8
80
*
H03BB01
ATC
carbimazole; oral
55.3
80.8
96
18
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
198.3
74.6
77
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
137.5
63.2
67
5
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
622.6
62.0
61
*
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
+∞
57.5
55
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
5.3
56.3
182
367
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
+∞
50.2
48
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
49.1
47
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
9.9
48.1
99
104
E04.8
ICD-10 Finland
Other specified nontoxic goitre
106.7
38.8
42
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
101.6
36.8
40
*
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
+∞
35.5
34
*
E04
ICD-10 Finland
Other nontoxic goitre
47.4
34.7
42
9
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
33.4
571
3331
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
75.2
32.9
37
5
BAA30
NOMESCO Finland
Excision of thyroid isthmus
+∞
31.3
30
*
24199
ICD-8 Finland
Non-toxic nodular goitre, Unspecified
+∞
31.3
30
*
TBA20
NOMESCO Finland
Aspiration cytology of thyroid gland
316.5
30.9
31
*
QX3LT
NOMESCO Finland
Subcutaneous sclerotherapy
68.8
29.9
34
5
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
+∞
29.2
28
*
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
53.9
27.2
32
6
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.0
27.0
167
590
106
Kela drug reimbursment
Hypoparathyroidism
52.2
26.2
31
6
A02BC05
ATC
esomeprazole; systemic
1.6
26.1
1043
7731
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
+∞
25.0
24
*
E06.1
ICD-10 Finland
Subacute thyroiditis
+∞
24.0
23
*
BAA25
NOMESCO Finland
Bilateral partial excision of thyroid gland
+∞
24.0
23
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
12.5
23.6
42
34
N02BE01
ATC
paracetamol; systemic, rectal
1.7
23.4
2186
19670
E07.9
ICD-10 Finland
Disorder of thyroid, unspecified
45.4
22.4
27
6
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
221.8
21.6
22
*
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
221.8
21.6
22
*
R13
ICD-10 Finland
Dysphagia
2.5
21.6
170
696
E06.3
ICD-10 Finland
Autoimmune thyroiditis
28.3
20.9
28
10
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
77.4
20.7
23
*
T81
ICPC
Goitre
18.4
20.4
31
17
E06.9
ICD-10 Finland
Thyroiditis, unspecified
74.1
19.7
22
*
2506
FHL
Thyroidectomy
201.4
19.6
20
*
BA1AE
SPAT
NA
8.6
18.2
39
46
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
+∞
17.7
17
*
E07.89
ICD-10 Finland
Other specified disorders of thyroid
37.0
17.6
22
6
4CJ01
NOMESCO Finland
NA
181.2
17.5
18
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
17.5
626
4420
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
29.0
17.4
23
8
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
16.7
843
6407
1930A
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]
+∞
16.7
16
*
T71
ICPC
Malignant neoplasm thyroid
+∞
16.7
16
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
16.2
529
3644
T72
ICPC
Benign neoplasm thyroid
21.1
16.0
23
11
R49.08
ICD-10 Finland
Other specified dysphonia
3.7
15.9
69
189
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
+∞
15.6
15
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
15.0
658
4838
R49.01
ICD-10 Finland
Functional dysphonia
2.9
14.7
90
318
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.8
14.0
87
312
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
14.0
524
3714
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
13.9
245
1411
J01FA10
ATC
azithromycin; systemic
1.4
13.9
1398
11925
A02BC02
ATC
pantoprazole; systemic
1.4
13.7
1550
13467
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
+∞
13.5
13
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
+∞
13.5
13
*
A11CC02
ATC
dihydrotachysterol; oral
34.2
13.5
17
5
BAA99
NOMESCO Finland
Other operation on thyroid gland
140.7
13.5
14
*
EP1AE
SPAT
NA
4.3
13.4
49
116
R01AD09
ATC
mometasone; nasal
1.4
13.0
1066
8750
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
12.8
801
6266
BA2AT
NOMESCO Finland
Biopsy of thyroid with ultrasound quidance
32.2
12.6
16
5
M54.5
ICD-10 Finland
Low back pain
1.4
12.5
752
5834
2419X
ICD-9 Finland
Non-toxic nodular goitre, Unspecified non-toxic nodular goitre
+∞
12.5
12
*
M01AE02
ATC
naproxen; oral, rectal
1.4
12.4
1344
11503
J37.0
ICD-10 Finland
Chronic laryngitis
2.6
12.1
87
340
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
11.8
378
2575
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
16.5
11.7
18
11
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.8
11.5
220
1302
R03AC02
ATC
salbutamol; inhalant
1.3
11.5
1234
10499
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
+∞
11.5
11
*
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
+∞
11.5
11
*
BWD00
NOMESCO Finland
Reoperation for deep haemorrhage in endocrine surgery
120.5
11.4
12
*
SPAT1263
SPAT
Sampling
1.3
11.3
971
7976
ZXA05
NOMESCO Finland
Left side
1.4
11.3
567
4245
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
11.1
531
3935
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
3.5
11.1
51
149
ZXA00
NOMESCO Finland
Right side
1.4
11.0
607
4625
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
10.9
230
1402
ZSB00
NOMESCO Finland
Procedure related to previous procedure classified in chapter B
43.5
10.9
13
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
10.9
557
4180
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.9
10.8
43
112
R51.80
ICD-10 Finland
Headache
1.6
10.7
329
2216
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
10.6
1150
9752
R01AD08
ATC
fluticasone; nasal
1.4
10.5
657
5107
S04
ICPC
Lump/swelling localized
1.7
10.5
201
1190
GB1AA
NOMESCO Finland
Tracheal X-ray examination
110.4
10.4
11
*
2411A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic multinodular goitre
+∞
10.4
10
*
8340/3-C73.9
ICD-O-3
Papillary carcinoma, follicular variant of thyroid gland
+∞
10.4
10
*
M25.5
ICD-10 Finland
Pain in joint
1.4
10.4
653
5083
A11CC03
ATC
alfacalcidol; systemic
3.2
10.3
52
164
J01DB01
ATC
cefalexin; oral
1.4
10.2
1949
17912
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
10.2
276
1803
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
10.1
915
7538
J01FA09
ATC
clarithromycin; systemic
1.4
10.0
736
5871
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
7.4
9.7
22
30
A02BC01
ATC
omeprazole; systemic
1.4
9.6
604
4691
ZX114
NOMESCO Finland
Intramuscular
3.6
9.5
41
115
Z50.5
ICD-10 Finland
Speech therapy
3.9
9.5
37
95
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
9.4
377
2687
T15
ICPC
THYROID LUMP/MASS
30.1
9.4
12
*
T85
ICPC
Hyperthyroidism/thyrotoxicosis
17.6
9.4
14
8
E05.89
ICD-10 Finland
Other thyrotoxicosis
+∞
9.4
9
*
8341/3-C73.9
ICD-O-3
Papillary microcarcinoma of thyroid gland
+∞
9.4
9
*
C07AA05
ATC
propranolol; systemic
1.4
9.4
424
3104
J01AA02
ATC
doxycycline; systemic
1.3
9.2
1905
17528
G47.3
ICD-10 Finland
Sleep apnoea
1.5
9.1
384
2769
A02BC04
ATC
rabeprazole; oral
1.7
9.1
195
1197
R00.2
ICD-10 Finland
Palpitations
1.8
9.0
160
930
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
8.6
681
5471
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
8.6
1254
10952
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
3.9
8.6
34
89
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
12.8
8.4
14
11
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
8.3
559
4375
24110
ICD-8 Finland
Non-toxic nodular goitre, Sporadic
+∞
8.3
8
*
A12AA04
ATC
calcium carbonate; oral
3.6
8.3
35
97
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
8.2
930
7846
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.1
8.2
93
461
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.9
8.1
121
663
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.8
8.1
32
84
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
1.6
8.1
231
1531
A02BA02
ATC
ranitidine; systemic
1.4
8.1
418
3133
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
8.0
1622
14710
C07AB07
ATC
bisoprolol; oral
1.3
8.0
960
8157
R07.0
ICD-10 Finland
Pain in throat
1.8
8.0
129
726
XKD00
NOMESCO Finland
Uroflowmetry
1.6
7.9
214
1399
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.9
889
7484
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
7.9
130
737
J01DA01
ATC
[U] cefalexin; systemic
1.3
7.9
1451
12993
SPAT1312
SPAT
General health counselling
1.3
7.9
710
5800
R42
ICD-10 Finland
Dizziness and giddiness
1.4
7.8
463
3545
R01AD12
ATC
fluticasone furoate; nasal
1.3
7.6
643
5200
A77
ICPC
Viral disease other/NOS
2.2
7.6
76
357
E83.51
ICD-10 Finland
Hypocalcemia
6.7
7.6
18
27
SPAT1211
SPAT
Application of soft bandage
1.6
7.5
187
1196
UKC02
NOMESCO Finland
Cystoscopy
1.5
7.5
265
1841
UJF32
NOMESCO Finland
Coloscopy
1.3
7.4
542
4290
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
80.3
7.4
8
*
C739
ICD-10 Finland
NA
80.3
7.4
8
*
Z00.0
ICD-10 Finland
General medical examination
1.4
7.4
387
2897
Z01.2
ICD-10 Finland
Dental examination
1.3
7.4
924
7864
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
7.4
216
1438
M01AB05
ATC
diclofenac; systemic, rectal
1.3
7.4
1552
14065
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
7.3
450
3468
L01
ICPC
Neck symptom/complaint
1.4
7.3
300
2150
R52.9
ICD-10 Finland
Pain, unspecified
1.6
7.3
172
1083
N03AX16
ATC
pregabalin; oral
1.3
7.3
510
4010
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
+∞
7.3
7
*
2502
FHL
Thyroid exploration and possible biopsy
+∞
7.3
7
*
C05AA08
ATC
fluocortolone; rectal, topical
1.4
7.3
305
2197
M01AH05
ATC
etoricoxib; oral
1.3
7.2
1362
12174
SPAT1153
SPAT
Removal of sutures
1.3
7.2
692
5693
R12
ICD-10 Finland
Heartburn
1.7
7.1
151
923
A12AA06
ATC
calcium lactate gluconate; oral
30.1
7.1
9
*
BA3AT
SPAT
NA
30.1
7.1
9
*
K07.60
ICD-10 Finland
Snapping jaw
1.8
7.1
111
620
R03BA05
ATC
fluticasone; inhalant
1.4
7.1
390
2949
J01FA06
ATC
roxithromycin; oral
1.3
7.0
910
7774
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
7.0
277
1967
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
4.1
7.0
25
61
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
7.0
734
6108
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
3.3
7.0
33
102
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
6.9
1227
10860
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.2
6.8
64
294
J02AC01
ATC
fluconazole; systemic
1.3
6.8
1013
8784
M01AC06
ATC
meloxicam; systemic, rectal
1.3
6.8
833
7059
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
6.8
814
6879
K30
ICD-10 Finland
Functional dyspepsia
1.5
6.7
229
1580
E06
ICD-10 Finland
Thyroiditis
22.6
6.7
9
*
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.5
6.6
194
1295
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
6.5
218
1499
62630
ICD-8 Finland
Disorders of menstruation, Painful
3.5
6.5
28
81
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
6.5
627
5150
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
6.4
163
1050
A98
ICPC
Health maint/preventive medicine
1.5
6.3
2441
23705
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
6.3
854
7306
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.5
6.3
238
1675
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
6.3
391
3013
R05FB02
ATC
cough suppressants and expectorants
1.3
6.3
853
7304
R21
ICPC
Throat symptom/complaint
1.4
6.3
389
2995
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
6.3
233
1637
8290/3-C73.9
ICD-O-3
Oxyphilic adenocarcinoma of thyroid gland
+∞
6.3
6
*
R06.0
ICD-10 Finland
Dyspnoea
1.3
6.2
492
3929
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
6.2
1049
9203
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
2.4
6.2
47
194
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
6.3
6.2
15
24
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
6.1
244
1737
L03
ICPC
Low back symptom/complaint
1.3
6.1
512
4120
G44.2
ICD-10 Finland
Tension-type headache
1.4
6.1
289
2126
XA402
NOMESCO Finland
ENMG
2.2
6.1
59
277
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
6.1
170
1123
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.6
6.1
150
961

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
172
16
114.30
307.65
6.4
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
445
563
9.17
307.65
1.5
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
487
797
7.16
293.34
4.0
1.7
pmol/l
4.6
4.5
1.10
441
702
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
181
73
26.40
260.03
6.5
1.2
u/ml
174.3
261.0
—
58
9
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2562
18319
4.76
165.46
6.7
2.6
pmol/l
15.3
14.4
57.04
2409
16525
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1719
11766
2.15
84.01
6.3
6.1
mmol/l
1.2
1.2
0.13
1455
9926
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2670
22251
3.92
83.51
8.0
3.5
mu/l
1.9
2.0
0.36
2509
20293
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
366
1268
3.16
81.21
1.3
1.1
iu/ml
93.7
79.8
0.30
121
411
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
142
275
5.38
69.87
1.5
1.2
iu/l
3.9
2.2
0.76
33
53
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1513
10627
1.90
60.15
5.3
5.5
mmol/l
1.2
1.2
0.42
1374
9578
(3013512) EKG study
1087
6882
1.93
59.15
4.0
3.8
—
—
—
0
0
(3019225) pH of Specimen
486
2340
2.30
54.66
4.2
4.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2155
17999
1.80
38.77
4.5
4.1
mm/h
11.0
12.5
6.30
1998
16646
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1381
10320
1.65
37.04
2.4
2.2
nmol/l
81.1
78.8
2.26
1231
9275
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
351
1725
2.18
36.66
2.9
3.5
ng/l
63.6
88.1
11.23
287
1473
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
513
2987
1.87
33.07
4.8
4.4
%
33.1
32.9
0.08
370
1968
(40768804) Tissue Pathology biopsy report
1342
10488
1.53
26.30
2.2
2.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2139
18640
1.58
24.21
7.6
7.4
u/l
76.2
77.5
0.75
2022
17481
(3044640) Blood type and Crossmatch panel - Blood
1023
7709
1.51
22.87
2.2
2.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1119
8602
1.49
22.64
3.7
3.4
ng/l
40.0
97.7
0.51
741
5654
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1416
11449
1.47
21.97
3.7
3.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2505
22897
1.75
21.38
13.7
12.4
ml/min/173m2
80.0
80.8
1.10
2188
18778
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2605
24185
1.85
19.73
14.3
13.4
mg/l
18.4
23.2
12.96
2118
18935
(3002030) Lymphocytes/100 leukocytes in Blood
1397
11441
1.43
19.24
5.8
6.0
%
28.9
28.2
1.79
1286
10643
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
326
1940
1.77
18.90
4.3
3.5
mmol/l
1.2
1.2
0.02
298
1678
(3018010) Neutrophils/100 leukocytes in Blood
1379
11304
1.42
18.68
5.5
5.8
%
56.6
57.2
1.27
1285
10547
(3019550) Sodium [Moles/volume] in Serum or Plasma
2659
24920
1.93
18.48
15.9
14.9
mmol/l
139.9
139.7
3.76
2601
24294
(3019069) Monocytes/100 leukocytes in Blood
1362
11161
1.42
18.37
5.8
6.2
%
8.4
8.5
0.56
1272
10438
(3015377) Calcium [Moles/volume] in Serum or Plasma
1054
8265
1.44
18.09
2.9
3.4
mmol/l
2.3
2.4
4.31
903
7192
(3023103) Potassium [Moles/volume] in Serum or Plasma
2663
24996
1.92
18.02
16.0
15.0
mmol/l
3.9
3.9
2.73
2599
24307
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2545
23596
1.70
17.66
5.0
4.4
mmol/l
5.8
5.9
0.14
2312
21520
(3013115) Eosinophils [#/volume] in Blood
1469
12250
1.41
17.65
5.7
6.0
e9/l
0.2
0.2
0.12
1316
10715
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
963
7453
1.44
17.64
2.5
2.5
u/l
54.8
57.3
1.63
898
6866
(3006504) Eosinophils/100 leukocytes in Blood
1350
11102
1.41
17.54
5.6
6.0
%
2.9
2.8
0.33
1245
10330
(3036481) Cortisol [Moles/volume] in Serum or Plasma
333
2035
1.72
17.53
2.3
2.0
nmol/l
366.0
371.8
0.22
305
1864
(3002256) Pathology report gross observation
481
3240
1.58
17.24
1.3
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
913
7036
1.44
16.97
4.5
3.8
ph
7.4
7.4
0.37
207
1301
(1761482) Bacteria [#/volume] in Urine by Culture
132
598
2.27
16.67
4.6
4.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2675
25253
1.89
16.18
14.3
12.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
488
3354
1.55
15.90
1.2
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1413
11838
1.38
15.80
5.5
5.8
e9/l
0.0
0.0
0.03
1259
10175
(3001604) Monocytes [#/volume] in Blood
1407
11784
1.38
15.74
5.6
5.8
e9/l
0.6
0.6
0.43
1259
10130
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2567
23983
1.67
15.67
4.8
4.3
mmol/l
4.8
4.8
0.39
2361
22190
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2475
22922
1.58
15.63
4.3
3.8
mmol/l
1.3
1.3
0.54
2253
20938
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
773
5854
1.44
15.53
2.2
2.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1440
12127
1.38
15.46
5.7
5.8
e9/l
1.9
1.9
0.85
1290
10640
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1791
15643
1.39
15.26
3.1
3.0
u/l
41.8
44.9
1.09
1658
14519
(3022096) Basophils/100 leukocytes in Blood
1299
10774
1.38
15.26
5.7
6.0
%
0.7
0.7
0.53
1202
10032
(3013826) Glucose [Moles/volume] in Serum or Plasma
1596
13692
1.37
15.13
3.8
4.3
mmol/l
6.5
6.6
0.79
1510
12757
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
99
413
2.45
15.09
3.0
2.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2396
22089
1.52
14.83
6.0
5.4
mmol/mol
39.2
39.3
0.03
2204
20409
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2713
25810
1.96
14.82
11.1
10.2
u/l
24.4
24.5
0.14
2620
24894
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2549
23831
1.63
14.79
4.8
4.2
mmol/l
1.5
1.5
2.23
2335
21928
(3001019) Free T4 and TSH panel - Serum or Plasma
194
1066
1.88
14.54
2.0
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
896
7036
1.40
14.46
2.0
2.1
u/l
143.6
197.8
2.41
836
6591
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2597
24441
1.67
14.09
5.2
4.7
mmol/l
2.8
2.8
0.12
2374
22483
(3041096) Erythrocytes [Presence] in Urine by Automated
814
6317
1.40
13.99
4.0
3.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1469
12539
1.35
13.83
5.6
6.1
umol/l
10.4
10.8
0.81
1381
11892
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
594
4394
1.44
13.25
1.3
1.3
iu/ml
21.4
33.2
3.93
180
1374
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
567
4171
1.45
13.01
1.3
1.2
u/ml
7.4
11.6
1.09
223
1600
(3037467) Urinalysis macro (dipstick) panel - Urine
1873
16692
1.35
12.73
4.9
4.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
467
3328
1.48
12.59
1.4
1.3
titre
514.9
535.2
0.09
109
701
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
800
6301
1.37
12.28
3.2
2.8
ng/l
1029.2
1166.5
0.59
675
5372
(3038515) Glucose [Moles/volume] in Venous blood
100
464
2.20
11.99
3.5
3.0
mmol/l
7.1
7.5
0.96
100
457
(3033705) Calcium.ionized [Moles/volume] in Venous blood
69
272
2.57
11.91
2.4
2.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2786
26928
2.24
11.87
22.2
19.7
e9/l
257.6
258.2
0.20
2735
26231
(3004616) Nuclear Ab [Presence] in Serum
72
291
2.51
11.81
1.3
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1214
10230
1.32
11.76
3.1
2.8
ug/l
114.7
112.2
0.14
1121
9487
(3000963) Hemoglobin [Mass/volume] in Blood
2787
26950
2.24
11.72
22.3
19.8
g/l
134.7
133.3
7.26
2760
26563
(3026361) Erythrocytes [#/volume] in Blood
2786
26943
2.22
11.60
22.2
19.7
e12/l
4.5
4.4
9.16
2729
26164
(42870588) Differential panel, method unspecified - Blood
978
8004
1.34
11.55
5.6
5.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2786
26946
2.22
11.54
22.2
19.7
e9/l
6.5
6.6
3.29
2730
26156
(3024731) MCV [Entitic volume]
2785
26938
2.20
11.45
22.1
19.6
fl
90.8
91.1
3.03
2758
26554
(3008037) Lactate [Moles/volume] in Venous blood
102
487
2.13
11.40
3.5
2.9
mmol/l
1.4
1.6
1.35
102
477
(3035941) MCH [Entitic mass]
2784
26939
2.17
11.19
22.1
19.6
pg
30.2
30.2
1.17
2757
26553
(40760892) CBC W Ordered Manual Differential panel - Blood
659
5107
1.38
11.00
4.4
4.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
16
22
7.31
10.98
1.9
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
258
1666
1.60
10.86
2.5
2.7
e9/l
4.0
4.0
0.09
191
1290
(3035637) Corticotropin [Mass/volume] in Plasma
62
244
2.58
10.77
2.0
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1577
13887
1.30
10.65
8.6
9.1
e9/l
3.9
4.0
1.95
1421
12088
(3000330) Specific gravity of Urine by Test strip
206
1273
1.67
10.33
4.0
3.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
687
5409
1.36
10.28
1.3
1.2
u/ml
0.8
1.6
3.52
181
1398
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1145
9696
1.30
10.26
2.0
1.9
pmol/l
100.7
96.7
1.78
579
4739
(3021589) Normoblasts [#/volume] in Blood
1236
10617
1.29
9.78
9.6
9.1
e9/l
0.0
0.0
0.98
1075
8604
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
622
4874
1.35
9.51
1.7
1.6
pmol/l
45473275.4
43232962.8
0.03
497
4034
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
196
1234
1.63
9.16
2.8
3.6
mmol/l
1.6
2.0
0.63
135
931
(4035726)
328
2319
1.47
9.07
1.3
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
202
1286
1.61
9.02
2.8
3.6
ph
7.4
7.4
0.20
16
166
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
204
1307
1.60
8.88
2.8
3.6
kpa
5.1
5.2
0.64
187
1205
(3032080) INR in Blood by Coagulation assay
1084
9238
1.28
8.86
7.4
8.5
inr
1.2
1.2
0.67
323
2653
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
140
815
1.75
8.76
3.0
4.0
mmol/l
24.9
25.0
0.20
127
752
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
46
181
2.57
8.08
1.2
1.2
u/ml
72.5
58.2
—
6
10
(3022217) INR in Platelet poor plasma by Coagulation assay
382
2841
1.40
7.98
17.5
23.1
inr
1.2
1.3
0.37
54
404
(3019309) Folate [Moles/volume] in Red Blood Cells
520
4064
1.34
7.95
1.7
1.7
nmol/l
1047.5
1178.7
2.64
397
3052
(3025159) Blasts/100 leukocytes in Blood
258
1786
1.49
7.93
3.6
4.3
%
2.4
0.2
0.65
55
442
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
152
932
1.67
7.90
4.3
3.7
%
46.2
48.4
0.55
152
922
(3021440) Promyelocytes/100 leukocytes in Blood
270
1888
1.47
7.89
3.6
4.3
%
0.3
0.1
1.06
60
507
(3022313) Gas panel - Capillary blood
150
922
1.66
7.73
2.8
3.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1050
9033
1.26
7.62
4.5
3.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1343
11897
1.24
7.45
5.9
4.9
estimate
0.0
0.0
0.80
267
2121
(3013139) Helicobacter pylori Ag [Presence] in Stool
246
1713
1.48
7.35
1.3
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
223
1526
1.50
7.26
1.3
1.3
au/ml
18.7
47.8
—
7
69
(3017181) Myelocytes/100 leukocytes in Blood
277
1980
1.44
7.22
3.6
4.2
%
1.2
0.9
0.64
62
549
(3009214) Lutropin [Units/volume] in Serum or Plasma
82
432
1.92
7.13
1.2
1.3
u/l
13.6
14.1
0.12
69
350
(3009261) Glucose [Presence] in Urine by Test strip
1352
12025
1.24
7.10
4.3
3.7
estimate
0.0
0.0
1.08
269
2112
(3048689) Calprotectin [Mass/mass] in Stool
388
2960
1.36
6.90
2.1
2.2
ug/g
102.3
108.8
0.20
287
2298
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
151
960
1.60
6.84
1.9
1.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
254
1805
1.45
6.84
3.5
4.0
%
1.3
0.5
0.76
48
411
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
240
1690
1.46
6.78
2.4
2.4
au/ml
20.7
24.8
0.26
12
93
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
47
204
2.33
6.75
1.5
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
359
2715
1.37
6.75
1.2
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
69
351
1.99
6.66
1.2
1.4
u/l
23.5
32.2
1.15
57
293
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
116
696
1.69
6.60
1.4
1.2
u/ml
26.3
33.7
—
9
42
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
107
629
1.73
6.55
1.4
1.3
u/ml
1.7
8.0
0.74
14
66
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
108
637
1.72
6.54
1.4
1.3
u/ml
2.9
4.7
0.90
25
114
(3020682) Albumin/Creatinine [Ratio] in Urine
815
6934
1.25
6.26
4.2
3.9
mg/mmol
9.7
8.6
0.17
474
4127
(3007164) IgA [Mass/volume] in Serum or Plasma
570
4662
1.28
6.11
1.5
1.4
g/l
2.3
2.4
0.88
356
2749
(3021960) Folate [Moles/volume] in Serum or Plasma
655
5450
1.26
6.09
1.5
1.5
nmol/l
21.0
20.9
0.04
556
4594
(3012095) Magnesium [Moles/volume] in Serum or Plasma
460
3674
1.30
5.92
3.0
3.2
mmol/l
0.8
0.8
2.05
431
3423
(3035350) Ketones [Presence] in Urine by Test strip
1316
11821
1.21
5.84
4.2
3.7
estimate
0.0
0.0
0.50
266
2097
(3017446) Testosterone [Moles/volume] in Serum or Plasma
126
800
1.60
5.79
2.0
2.0
nmol/l
12.1
11.7
0.23
106
694
(3003458) Phosphate [Moles/volume] in Serum or Plasma
367
2850
1.33
5.78
5.2
5.3
mmol/l
1.0
1.0
0.19
332
2639
(3026389) Candida sp identified in Specimen by Organism specific culture
66
349
1.91
5.74
1.5
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
676
5693
1.25
5.60
2.2
2.2
mg/l
3.0
3.0
0.06
582
4863
(3025941) Bacteria identified in Stool by Culture
193
1358
1.45
5.51
1.3
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
900
7825
1.22
5.49
3.2
3.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
49
237
2.09
5.48
1.3
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
259
1926
1.38
5.41
1.8
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
543
4488
1.26
5.28
3.3
2.7
mosm/kgh2o
524.5
531.4
0.32
473
3767
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
133
878
1.54
5.20
1.7
1.8
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
86
510
1.71
5.18
1.4
1.2
u/ml
1.1
4.3
—
9
39
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
141
945
1.52
5.14
1.6
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
806
6973
1.22
5.10
3.2
3.1
mmol/l
7.0
7.0
0.01
678
5825
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
118
762
1.57
5.09
2.0
2.0
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
184
1305
1.44
5.06
3.1
3.0
g/l
130.9
127.5
1.44
184
1279
(4024509)
49
248
1.99
4.89
1.5
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1951
20608
0.83
4.79
18.4
17.1
g/l
331.6
331.4
0.47
1938
20474
(1761868) Lipid panel - Serum or Plasma
952
8409
1.20
4.79
3.1
2.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
116
759
1.55
4.74
2.1
2.0
u/l
4000.0
4414.0
0.07
42
311
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
56
302
1.87
4.66
1.3
1.3
nmol/l
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
629
5367
1.22
4.50
2.1
1.7
mg/l
1.0
1.1
0.74
500
4109
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
140
965
1.47
4.50
1.7
2.0
u/l
39.0
39.4
0.10
124
868
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
144
999
1.46
4.48
2.6
2.7
%
1.1
1.2
0.25
144
991
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
40
196
2.06
4.39
1.4
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
756
6587
1.20
4.34
3.3
3.2
mg/l
526.1
401.3
0.24
415
3911
(3031040) Bacteria [#/volume] in Urine by Automated count
1732
16181
1.18
4.34
5.1
4.4
e6/l
1944.3
2446.3
0.15
20
201
(3015171) Extractable nuclear Ab [Units/volume] in Serum
142
989
1.46
4.34
1.4
1.3
u/ml
0.2
1.0
1.65
13
91
(3002032) Base excess in Venous blood by calculation
249
1908
1.33
4.32
3.9
3.6
mmol/l
1.9
2.0
0.28
212
1574
(3000570) Elastase.pancreatic [Mass/mass] in Stool
106
697
1.54
4.27
1.2
1.4
ug/g
320.0
289.8
0.97
55
386
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
53
292
1.83
4.16
1.7
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
265
2062
1.31
4.14
3.5
3.1
ug/l
0.8
0.8
0.32
187
1413
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
53
294
1.82
4.08
1.5
2.1
mg/l
28.4
25.5
—
10
75
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
277
2180
1.30
3.99
1.9
2.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
57
326
1.76
3.98
1.3
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
53
297
1.80
3.96
1.8
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
52
291
1.80
3.90
1.8
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
61
358
1.72
3.90
1.3
1.3
nmol/l
0.2
0.4
—
5
20
(3025468) Yersinia sp identified in Specimen by Organism specific culture
51
286
1.80
3.81
1.8
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
51
286
1.80
3.81
1.8
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
51
286
1.80
3.81
1.8
1.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
38
194
1.97
3.77
1.2
1.1
nmol/l
307.3
385.3
1.50
26
174
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
173
1288
1.37
3.66
1.1
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
114
789
1.46
3.65
2.9
3.2
g/l
0.4
0.3
0.59
38
305
(3004789) Transferrin [Mass/volume] in Serum or Plasma
383
3170
1.24
3.64
2.5
2.3
g/l
2.4
2.3
0.56
354
2939
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
24
106
2.27
3.45
1.8
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
212
1646
1.31
3.40
3.7
2.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
412
3463
1.22
3.39
2.6
2.4
umol/l
13.0
13.1
0.18
380
3210
(3003327) Ova and parasites identified in Stool by Light microscopy
108
754
1.45
3.33
1.9
1.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1120
10251
1.15
3.33
4.0
4.6
g/l
36.0
35.6
2.05
1035
9531
(3002582) Erythrocytes [#/volume] in Urine
785
6999
1.17
3.32
3.6
3.1
e6/l
26.6
70.0
2.87
630
5261
(3005322) IgE [Units/volume] in Serum or Plasma
198
1530
1.32
3.30
1.2
1.3
u/ml
106.0
197.6
2.77
178
1411
(3004588) Protein electrophoresis panel - Serum or Plasma
199
1540
1.31
3.28
2.1
2.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
28
136
2.07
3.22
1.6
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
495
4257
1.20
3.21
1.6
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
421
3568
1.21
3.19
5.7
5.1
ug/l
2.5
2.9
0.49
372
3166
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
24
110
2.19
3.18
2.1
1.6
nmol/l
5.1
4.4
0.09
18
90
(3051387) C reactive protein [Mass/volume] in Capillary blood
77
512
1.52
3.05
3.1
3.3
mg/l
26.4
26.5
0.01
40
318
(3020630) Protein [Mass/volume] in Serum or Plasma
231
1843
1.28
3.04
2.3
2.8
g/l
67.0
66.6
0.35
204
1683
(3026493) Urate [Moles/volume] in Serum or Plasma
658
5834
1.17
2.96
2.5
2.4
umol/l
8866.2
5050.8
0.95
557
5042
(44813793)
33
176
1.89
2.95
1.1
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
35
191
1.84
2.92
2.3
2.0
u/field
2.2
2.1
0.01
13
70
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
95
669
1.43
2.85
1.3
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
31
3.23
2.77
1.6
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
349
2947
1.21
2.76
2.6
2.4
%
22.6
22.8
0.09
313
2508
(1616796) Gas panel - Central venous blood
66
437
1.52
2.70
2.9
3.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
21
419
0.50
2.70
1.6
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
63
414
1.53
2.67
1.7
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
287
2395
1.22
2.56
2.9
3.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
338
2870
1.20
2.53
4.7
4.4
%
21.4
21.1
0.11
184
1432
(3043410) Blood group antigens tested for on Red Blood Cells
14
56
2.51
2.53
2.9
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
23
115
2.01
2.50
3.0
2.9
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
11
39
2.83
2.47
1.8
1.3
ng/l
132.4
85.5
0.43
11
39
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
211
1711
1.25
2.47
1.6
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
286
2397
1.21
2.46
2.2
2.5
%
1.7
1.8
0.77
255
2129
(3018095) Leukocytes [#/volume] in Urine
909
8339
1.13
2.45
4.3
3.5
e6/l
91.1
112.1
0.41
675
5714
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
218
1779
1.24
2.42
2.9
3.8
u/ml
90.7
58.2
0.24
211
1721
(3003694) ABO and Rh group [Type] in Blood
721
6522
1.14
2.41
1.5
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
65
441
1.48
2.41
2.4
2.8
kpa
8.2
8.1
0.18
60
406
(3029937) Albumin [Presence] in Urine by Test strip
696
6283
1.14
2.40
4.5
4.1
estimate
0.0
0.0
1.28
266
2093
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
192
0.36
2.39
1.3
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
136
1049
1.31
2.37
1.2
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
213
1738
1.24
2.37
2.8
2.7
g/l
10.2
10.4
0.57
190
1598
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
21
104
2.03
2.36
1.8
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
21
104
2.03
2.36
1.8
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
46
708
0.64
2.33
3.5
5.6
mmol/l
1.3
1.2
0.25
40
617
(40761536) Microorganisms panel - Urine sediment
242
2008
1.22
2.31
4.6
4.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
99
737
1.36
2.22
2.4
2.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
14
61
2.30
2.14
4.1
3.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
74
529
1.41
2.12
1.7
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
419
3682
1.16
2.11
3.0
2.7
e6/l
3.4
3.4
0.04
278
1931
(4146454)
38
236
1.62
2.10
3.7
2.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
19
95
2.01
2.10
2.3
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
19
95
2.01
2.10
2.3
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
19
95
2.01
2.10
2.3
1.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
289
2464
1.19
2.10
5.6
4.1
u/l
236.0
250.0
0.83
268
2331
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
74
532
1.40
2.06
1.4
1.2
u/ml
26.7
43.2
—
9
68
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
14
63
2.23
2.01
1.1
1.2
pmol/l
152.4
46.7
—
5
18
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
35
216
1.63
2.00
2.9
2.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1593
15206
1.11
1.99
2.9
2.9
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
170
1383
1.24
1.98
2.1
1.8
g/l
1.4
1.4
0.12
150
1269
(3003888) Timothy IgE Ab [Units/volume] in Serum
55
379
1.46
1.94
1.1
1.1
u/ml
6.0
4.7
0.17
28
186
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
8
27
2.97
1.93
1.0
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
72
522
1.39
1.93
2.2
2.9
mmol/l
24.4
25.0
0.51
63
454
(3023520) Reticulocytes [#/volume] in Blood
213
1784
1.21
1.89
2.2
2.6
e9/l
70.7
70.4
0.05
166
1318
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
25
143
1.75
1.89
3.2
2.6
e6/l
697.7
775.4
0.26
14
57
(3000093) Morphology [Interpretation] in Blood Narrative
30
181
1.66
1.88
1.3
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
90
680
1.33
1.88
1.5
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
238
2020
1.19
1.84
1.2
1.2
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
5
12
4.17
1.82
1.2
1.3
u/l
199.0
329.8
—
5
12
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
307
2666
1.17
1.82
3.5
4.0
ug/l
21.6
19.3
0.08
238
2131
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
25
145
1.73
1.81
1.7
1.3
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
23
131
1.76
1.77
1.1
1.2
u/l
18.4
25.0
0.46
17
98
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
23
131
1.76
1.77
1.1
1.2
u/l
60.8
83.3
1.51
18
100
(3043238) Trisomy 21 risk [Likelihood] in Fetus
25
412
0.60
1.77
1.4
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
84
635
1.33
1.76
1.4
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
24
399
0.60
1.76
1.5
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
113
1422
0.79
1.75
3.7
4.5
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
6
18
3.34
1.74
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
70
516
1.37
1.73
2.9
3.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
24
397
0.60
1.73
1.5
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
64
465
1.38
1.73
3.2
3.8
%
55.7
57.6
0.60
64
465
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
13
3.85
1.71
1.2
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
5
13
3.85
1.71
1.2
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
97
752
1.30
1.71
2.0
1.7
g/l
1.2
1.2
0.42
86
713
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
89
682
1.31
1.71
3.0
3.2
ratio
1.4
1.8
—
8
50
(3018572) Chloride [Moles/volume] in Blood
33
505
0.65
1.70
3.7
6.3
mmol/l
105.7
105.0
0.45
28
448
(3039000) Anion gap in Blood
33
504
0.65
1.69
3.7
6.3
mmol/l
11.3
11.1
0.15
28
447
(3034860) Kappa light chains.free [Mass/volume] in Serum
91
701
1.31
1.69
2.9
3.3
mg/l
44.3
60.0
0.71
75
572
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
24
141
1.71
1.68
1.7
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
137
1114
1.24
1.65
1.1
1.1
—
174.2
—
0
24
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
94
730
1.30
1.65
2.1
1.7
g/l
0.2
0.2
0.40
84
693
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
79
599
1.33
1.64
1.8
2.1
mg/l
10.8
11.7
0.53
69
554
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
16
83
1.93
1.64
1.3
1.6
ug/l
0.6
0.4
—
10
57
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
20
112
1.79
1.64
2.3
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
20
112
1.79
1.64
2.3
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
20
112
1.79
1.64
2.3
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
20
112
1.79
1.64
2.3
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
91
705
1.30
1.63
2.9
3.3
mg/l
35.8
47.5
0.58
74
576
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
48
336
1.44
1.61
1.0
1.0
u/ml
1.0
3.0
1.90
14
143
(3045414) Leukocytes [Presence] in Urine
142
1164
1.23
1.60
2.0
1.9
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
32
2.50
1.59
1.1
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
32
2.50
1.59
1.1
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
8
32
2.50
1.59
1.3
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
32
2.50
1.59
1.1
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
143
1175
1.23
1.58
1.4
1.3
iu/l
29.7
32.9
0.55
127
1022
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
73
551
1.33
1.58
1.8
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
65
482
1.36
1.57
2.1
2.5
ug/min
99.0
83.3
0.22
38
286
(3036603) Volume of Urine
25
152
1.65
1.56
2.0
1.4
ml
1830.2
1611.5
—
10
22
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
33
2.43
1.53
1.3
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
836
7809
1.10
1.53
3.0
3.2
u/l
32.6
33.2
0.09
796
7413
(3018677) aPTT in Platelet poor plasma by Coagulation assay
389
3484
1.13
1.53
2.6
2.0
s
29.2
29.6
0.89
378
3364
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
15
3.34
1.52
1.0
1.0
—
—
—
0
0
(4094501)
80
617
1.31
1.50
1.0
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
319
2823
1.15
1.50
1.4
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
160
1338
1.21
1.50
2.4
2.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
153
1274
1.21
1.50
1.6
1.5
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
18
101
1.79
1.48
1.7
2.0
ug/l
21.2
98.2
0.49
18
90
(3027231) Wheat IgE Ab [Units/volume] in Serum
9
37
2.44
1.48
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
36
243
1.49
1.47
3.2
3.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
14
73
1.92
1.43
1.1
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
112
908
1.24
1.42
2.4
2.3
g/l
3.6
3.8
0.35
82
653
(3006442) Creatine [Moles/volume] in Serum or Plasma
23
141
1.64
1.41
1.2
1.5
—
66.6
—
0
12
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
88
694
1.28
1.41
2.7
2.3
g/l
0.0
0.0
0.39
82
642
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
209
1802
1.17
1.40
2.1
2.3
ug/l
7.0
6.3
0.18
174
1565
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
106
856
1.25
1.40
2.5
2.4
g/l
2.9
3.1
1.63
84
673
(3010421) pH of Blood
71
545
1.31
1.40
3.3
3.8
ph
7.4
7.4
1.61
58
453
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
407
3678
1.12
1.39
1.8
1.8
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
29
2.42
1.39
1.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
13
67
1.94
1.38
1.4
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
12
60
2.00
1.38
2.3
2.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
27
174
1.56
1.37
2.1
2.4
ml
747.3
660.5
0.49
20
119
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
18
104
1.74
1.37
2.3
2.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
23
2.61
1.36
1.8
2.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
104
841
1.25
1.36
2.4
2.3
g/l
10.3
10.3
0.01
88
720
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
32
215
1.49
1.35
2.7
3.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
707
6591
1.10
1.34
1.6
1.6
mmol/l
1.3
1.4
0.57
591
5555
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
97
780
1.25
1.34
2.6
2.4
g/l
0.9
0.9
0.06
86
687
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
39
0.00
1.33
0.0
1.3
—
1.9
—
0
26
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
111
907
1.23
1.33
2.4
2.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
42
299
1.41
1.33
1.4
1.3
pmol/l
270.4
278.1
0.04
28
238
(3021901) Oxygen saturation in Capillary blood
50
367
1.37
1.33
2.6
2.9
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
11
54
2.04
1.32
1.1
1.8
mmol/l
0.6
1.2
0.25
11
48
(3011412) CD3 cells [#/volume] in Blood
31
208
1.50
1.32
3.9
2.3
e9/l
1.1
1.1
0.02
17
132
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
111
908
1.23
1.32
2.4
2.3
g/l
7.2
7.4
0.91
85
690
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
43
2.10
1.30
1.1
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
83
658
1.27
1.30
1.2
1.2
titre
70.0
175.0
—
10
54
(40758558) Short blood count panel - Blood
662
6165
1.10
1.28
6.5
6.8
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
18
2.78
1.28
1.2
1.3
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
13
69
1.89
1.28
1.2
1.1
u/ml
0.7
2.3
—
5
31
(3037756) Immunofixation for Serum or Plasma
63
483
1.31
1.27
1.3
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
11
55
2.00
1.27
1.1
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
90
723
1.25
1.27
2.6
2.2
g/l
39.0
37.7
1.28
79
625
(3051593) INR in Capillary blood by Coagulation assay
17
99
1.72
1.27
6.9
11.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
33
227
1.46
1.26
1.1
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
60
458
1.32
1.25
3.4
3.8
mmol/l
2.6
2.7
0.05
43
325
(44816559) Phosphatidylethanol [Mass/volume] in Blood
51
380
1.35
1.25
1.2
1.3
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
25
2.40
1.24
1.3
3.0
u/field
1.3
0.8
—
6
25
(4062490)
33
228
1.45
1.24
2.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
21
324
0.65
1.20
1.3
1.5
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
23
148
1.56
1.20
1.3
1.8
mmol/l
6.2
6.8
0.82
17
97
(3009871) Measles virus Ab [Titer] in Serum
13
71
1.83
1.19
1.5
1.7
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
26
2.31
1.18
1.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
26
2.31
1.18
1.8
2.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
525
4868
1.10
1.13
3.0
2.5
e6/l
6.3
6.7
0.14
454
4220
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
237
2104
1.14
1.11
1.3
1.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
22
143
1.54
1.11
1.1
1.1
nmol/l
0.2
19.0
—
7
20
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
89
728
1.23
1.10
1.3
1.3
miu/ml
246.2
222.9
0.25
46
351
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
90
738
1.23
1.09
1.8
1.6
iu/ml
1.5
8.0
0.39
20
156
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
84
684
1.23
1.09
1.1
1.1
u/ml
0.9
6.6
—
6
71
(3008152) Bicarbonate [Moles/volume] in Arterial blood
115
1358
0.84
1.06
5.5
6.4
mmol/l
24.4
24.6
0.41
103
1249
(21494815) CD4 cells/100 lymphocytes in Specimen
27
186
1.46
1.06
3.0
2.2
%
45.6
41.6
—
8
21
(44806071)
7
33
2.12
1.05
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
19
121
1.57
1.05
1.1
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
687
6466
1.08
1.05
3.5
3.0
e6/l
0.3
0.5
1.25
543
4788
(3034274) Bile acid [Moles/volume] in Serum --fasting
36
263
1.37
1.03
2.1
2.1
umol/l
8.7
6.6
0.26
22
185
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
22
2.27
1.03
1.2
1.0
—
—
—
0
0
(44806420)
11
60
1.84
1.02
2.7
2.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
35
255
1.38
1.02
1.1
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
9
47
1.92
1.02
1.1
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
79
645
1.23
1.01
2.8
2.3
g/l
0.0
0.0
0.00
73
596
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
79
645
1.23
1.01
1.3
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
204
2297
0.88
1.01
2.3
2.3
u/l
36.1
39.7
0.45
169
1948
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
27
188
1.44
1.01
2.0
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
27
188
1.44
1.01
2.0
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
27
188
1.44
1.01
2.0
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
431
3984
1.10
1.00
2.9
2.6
e6/l
1.0
1.3
0.92
286
2216
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
7
35
2.00
1.00
1.4
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
56
440
1.28
0.99
1.1
1.1
u/ml
0.4
1.1
1.27
21
165
(3020779) Urea [Moles/volume] in Serum or Plasma
205
1821
1.14
0.98
7.6
7.1
mmol/l
9.3
9.2
0.06
191
1750
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
23
2.18
0.98
3.2
2.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
78
639
1.23
0.98
2.9
2.4
g/l
0.0
0.0
0.00
73
595
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
36
1.95
0.97
1.1
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
10
54
1.85
0.96
1.2
1.8
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
31
0.00
0.96
0.0
1.3
—
6.1
—
0
20
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
186
0.59
0.95
1.4
1.5
g/l
1.0
0.9
0.23
11
186
(3044927) Protein electrophoresis panel - Urine
32
233
1.38
0.95
1.2
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
47
364
1.30
0.94
1.1
1.1
u/ml
1.1
1.1
0.03
21
151
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
14
85
1.65
0.94
1.0
1.1
iu/ml
85.7
213.6
2.54
14
85
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
19
125
1.52
0.94
1.5
1.8
u/field
0.4
3.8
1.40
14
81
(3027923) C peptide [Moles/volume] in Serum or Plasma
19
125
1.52
0.94
2.2
1.5
nmol/l
1.0
1.3
0.52
14
95
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
157
1375
1.15
0.93
1.6
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
55
436
1.27
0.93
1.4
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
47
365
1.29
0.93
1.2
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
545
5109
1.08
0.92
4.3
4.1
kg/l
1.0
1.0
0.55
101
761
(3002523) Influenza virus A Ag [Presence] in Specimen
43
331
1.30
0.91
1.1
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
227
2513
0.89
0.88
4.6
6.8
kpa
5.0
5.1
0.76
212
2392
(40767503) Oxygen content in Capillary blood by calculation
56
449
1.25
0.87
2.1
2.6
%
16.2
15.9
0.21
32
223
(3027801) Oxygen [Partial pressure] in Arterial blood
227
2512
0.90
0.87
4.6
6.8
kpa
13.5
12.7
1.15
212
2392
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
32
238
1.35
0.86
2.1
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
299
2740
1.10
0.85
4.7
6.5
mmol/l
104.8
104.4
0.77
291
2690
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
17
112
1.52
0.84
2.5
3.0
u/ml
1050.0
844.7
0.19
17
112
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
44
344
1.28
0.84
1.4
1.4
nmol/l
0.3
0.4
0.36
32
258
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
16
104
1.54
0.84
2.4
3.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
31
231
1.35
0.83
1.1
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
100
1163
0.85
0.82
5.4
9.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
30
223
1.35
0.81
2.2
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
298
2739
1.10
0.81
1.7
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
47
373
1.26
0.81
1.1
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
49
391
1.26
0.81
1.7
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
227
2499
0.90
0.80
4.6
6.8
mmol/l
1.0
1.2
0.42
172
1939
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
86
1011
0.85
0.80
1.4
1.5
—
—
—
0
0
(4010399)
192
1725
1.12
0.80
1.4
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
635
6023
1.07
0.79
3.9
4.2
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
10
58
1.73
0.79
1.4
1.4
%
26.8
23.5
—
10
51
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
25
0.00
0.79
0.0
1.2
—
27.2
—
0
17
(3045683) HLA typing for celiac disease panel - Blood or Tissue
19
131
1.45
0.78
1.0
1.0
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
19
131
1.45
0.78
3.8
2.5
e9/l
0.3
0.2
0.85
19
114
(3003740) Influenza virus B Ag [Presence] in Specimen
42
331
1.27
0.77
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
21
292
0.72
0.77
2.3
2.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
50
403
1.24
0.77
1.3
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
6
34
1.77
0.76
1.7
1.4
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
3.0
—
1.3
—
0
21
(3017704) Immunofixation for Urine
16
107
1.50
0.76
1.2
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
315
2914
1.09
0.76
6.3
6.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
45
359
1.26
0.76
1.9
1.6
g/l
0.6
0.8
0.95
31
270
(3042111) Morphology [Interpretation] in Bone marrow Narrative
47
377
1.25
0.75
1.4
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
67
1.64
0.75
7.0
1.8
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
5
24
2.09
0.74
1.0
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
30
227
1.32
0.74
2.1
1.3
g/l
0.3
0.4
1.28
18
159
(3028192) IgG subclass 2 [Mass/volume] in Serum
30
227
1.32
0.74
2.1
1.3
g/l
3.0
2.9
0.13
17
161
(3027135) IgG subclass 1 [Mass/volume] in Serum
30
227
1.32
0.74
2.1
1.3
g/l
5.7
7.2
1.64
16
157
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
98
847
1.16
0.74
1.8
1.9
ug/l
1.5
2.3
0.48
82
760
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
63
754
0.83
0.74
1.7
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
96
829
1.16
0.73
1.1
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
41
325
1.27
0.73
1.0
1.1
iu/ml
48.0
1741.8
—
8
74
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
15
100
1.50
0.72
1.1
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
297
2747
1.09
0.72
2.3
2.7
umol/l
6.4
7.8
1.17
255
2371
(3034426) Prothrombin time (PT)
13
84
1.55
0.71
1.2
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
50
408
1.23
0.70
1.6
2.8
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
26
1.92
0.70
1.2
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
474
4475
1.07
0.69
2.8
3.0
mmol/l
2.4
2.5
1.32
421
3941
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
59
1.53
0.68
1.1
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
105
920
1.15
0.68
1.6
1.7
mg/l
3.8
3.8
0.01
82
659
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
221
2025
1.10
0.67
1.7
1.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
28
1.79
0.66
1.0
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
188
1.33
0.66
1.2
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
25
188
1.33
0.66
1.2
1.1
titre
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
167
0.66
0.66
1.1
1.7
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
7
44
1.59
0.65
1.1
1.3
—
152.2
—
0
10
(42529406) Shigella sp [Presence] in Stool by Culture
63
743
0.84
0.65
1.2
1.2
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
10
62
1.62
0.65
1.4
1.5
%
0.5
3.0
—
10
52
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
178
0.67
0.64
1.2
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
33
260
1.27
0.64
1.5
2.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
188
2058
0.91
0.63
4.8
7.6
g/l
121.3
119.9
0.38
179
1978
(3039162) Centromere protein B Ab [Units/volume] in Serum
39
314
1.25
0.63
1.4
1.3
u/ml
24.0
49.6
—
5
15
(3017354) Segmented neutrophils/100 leukocytes in Blood
28
216
1.30
0.63
2.7
3.4
%
56.7
56.6
0.00
23
149
(3016502) Oxygen saturation in Arterial blood
201
2192
0.91
0.63
4.8
7.3
%
96.4
95.9
0.77
190
2104
(3027008) Opiates [Presence] in Urine
71
608
1.17
0.63
1.4
1.8
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
79
1.52
0.62
4.2
1.9
—
—
—
0
0
(4306422)
43
351
1.23
0.62
1.2
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
50
415
1.21
0.62
1.5
1.2
u/ml
249.4
265.0
0.17
33
249
(3015183) Erythrocyte sedimentation rate
17
121
1.41
0.62
1.0
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
23
302
0.76
0.62
1.9
2.0
u/ml
813.0
880.1
0.02
23
288
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
11
71
1.55
0.62
1.4
1.5
%
63.3
65.8
0.09
11
57
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
235
2541
0.92
0.61
1.7
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
542
5686
0.94
0.61
4.0
3.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
154
1394
1.11
0.61
1.4
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
208
1912
1.09
0.61
4.3
6.6
mmol/l
1.2
1.3
0.76
201
1853
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
55
651
0.84
0.60
1.4
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.6
—
46.5
—
0
20
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
51
1.57
0.60
1.1
2.7
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
19
139
1.37
0.60
1.1
1.4
—
755.5
—
0
11
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
2.2
—
0.9
—
0
14
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
15
105
1.43
0.60
1.0
1.4
%
—
71.1
—
0
14
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
151
0.66
0.59
1.4
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
71
612
1.16
0.59
1.4
1.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
72
1.53
0.59
1.0
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
63
735
0.85
0.59
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
99
875
1.14
0.59
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
190
1744
1.10
0.58
5.6
8.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
54
1.48
0.57
1.5
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
35
283
1.24
0.56
1.2
1.2
u/l
59.5
55.5
0.18
23
196
(3045142) Bone marrow Pathology biopsy report
33
265
1.25
0.56
1.1
1.4
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
11
73
1.51
0.56
1.0
1.2
%
—
19.7
—
0
9
(3000764) Benzodiazepines [Presence] in Urine
70
606
1.16
0.56
1.4
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
56
476
1.18
0.56
1.5
1.8
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
40
329
1.22
0.56
1.3
1.2
u/l
21.6
44.0
1.17
35
281
(1617658) Protocol used for examination of sentinel lymph nodes
21
274
0.76
0.55
1.0
1.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
41
339
1.21
0.55
1.1
1.1
u/ml
0.2
2.6
—
6
79
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
126
0.63
0.54
1.0
1.2
—
—
—
0
0
(4198724)
9
61
1.48
0.53
1.3
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
64
553
1.16
0.53
1.4
1.9
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
41
491
0.83
0.53
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
41
491
0.83
0.53
1.3
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
24
187
1.29
0.52
1.5
1.1
u/ml
0.5
0.8
—
7
77
(3033658) Prothrombin time (PT) actual/Normal
633
6089
1.05
0.51
3.4
3.7
%
93.5
93.0
0.20
618
5931
(4281824)
43
360
1.20
0.51
1.0
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
43
360
1.20
0.51
2.7
3.5
%
2.2
1.4
0.52
37
289
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
64
1.41
0.51
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
64
1.41
0.51
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
64
1.41
0.51
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
64
1.41
0.51
1.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
136
0.66
0.51
1.3
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
71
621
1.15
0.51
2.2
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
49
416
1.18
0.51
1.2
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
30
242
1.24
0.51
1.3
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
61
528
1.16
0.50
1.6
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
19
144
1.32
0.50
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
43
361
1.19
0.50
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
534
5119
1.05
0.50
1.4
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
41
1.46
0.50
1.0
1.9
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
84
1.43
0.49
1.9
2.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
72
633
1.14
0.49
1.3
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
61
700
0.87
0.49
3.4
3.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
7
45
1.56
0.49
4.0
3.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
22
172
1.28
0.48
1.5
1.6
u/l
12.2
6.6
0.64
11
85
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
42
354
1.19
0.48
1.1
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
47
1.49
0.47
2.1
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
19
146
1.30
0.47
1.4
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
64
728
0.88
0.46
1.2
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
16
120
1.34
0.46
1.0
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
8
117
0.68
0.45
2.0
2.8
—
32.0
—
0
10
(3036071) Salmonella sp Ab [Titer] in Serum
5
84
0.59
0.45
1.4
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
26
210
1.24
0.45
3.1
2.7
mg/l
27.4
30.7
0.09
18
148
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
21
165
1.27
0.45
1.3
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
204
1906
1.08
0.44
3.4
3.6
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
12
86
1.40
0.44
12.7
14.1
mmol/l
0.7
0.6
0.68
12
78
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
51
1.37
0.44
2.1
4.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
51
1.37
0.44
2.1
4.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
29
238
1.22
0.44
1.5
1.4
mosm/kgh2o
275.4
276.2
0.07
24
182
(3036782) Glucose [Moles/volume] in Pleural fluid
15
196
0.76
0.42
1.5
1.5
mmol/l
6.2
6.6
0.18
15
187
(3020650) Glucose [Presence] in Urine
8
56
1.43
0.42
3.4
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
53
462
1.15
0.42
1.3
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2187
22083
0.96
0.42
15.2
14.4
%
38.8
39.2
0.92
1542
15883
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
70
1.43
0.41
1.1
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
30
249
1.21
0.41
1.0
1.1
—
—
—
0
0
(3036489) Thrombin time
96
871
1.11
0.41
2.4
1.9
s
22.0
21.5
0.29
86
750
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
60
529
1.14
0.41
1.6
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
16
0.00
0.41
0.0
1.2
—
21.7
—
0
8
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
40
466
0.86
0.41
1.7
1.6
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
0.2
—
0
8
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
58
511
1.14
0.40
3.0
3.1
u/ml
31.0
956.4
1.13
51
466
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
35
296
1.18
0.40
1.3
1.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
53
603
0.88
0.40
3.9
3.5
u/ml
15.5
29.4
3.67
53
586
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.1
—
45.5
—
0
5
(3006576) Bicarbonate [Moles/volume] in Blood
8
61
1.31
0.39
8.5
4.9
mmol/l
24.2
25.9
—
8
55
(21494814) CD8 cells/100 lymphocytes in Specimen
13
97
1.34
0.39
4.2
1.9
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
104
0.67
0.39
1.1
1.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
17
133
1.28
0.38
1.1
1.0
u/ml
0.2
3.1
—
8
41
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
33
388
0.85
0.38
1.5
1.6
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
11
80
1.38
0.38
1.5
2.4
—
36954.8
—
0
13
(3005011) Chlamydia sp Ab [Titer] in Serum
5
36
1.39
0.38
1.8
1.6
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
36
1.39
0.38
1.0
1.1
mg/g
10.3
7.2
—
5
36
(3044941) Cell count panel - Synovial fluid
32
377
0.85
0.38
1.6
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
35
298
1.18
0.38
1.4
1.5
%
54.4
58.8
0.29
21
189
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
22
179
1.23
0.37
1.3
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
204
1923
1.07
0.37
3.0
2.5
ml/min/173m2
65.7
66.8
0.17
98
745
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
116
0.69
0.37
1.4
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
116
0.69
0.37
1.6
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
67
601
1.12
0.36
1.4
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
38
438
0.87
0.35
1.3
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
42
367
1.15
0.34
1.2
1.2
u/ml
8.6
5.0
0.52
19
128
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
83
908
0.91
0.34
1.4
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
12
91
1.32
0.33
1.2
1.1
miu/ml
1781.8
1562.7
0.20
12
91
(3017143) Hepatitis C virus Ab [Presence] in Serum
264
2518
1.05
0.33
1.5
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
342
3284
1.05
0.33
1.6
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
86
0.70
0.33
1.2
1.2
—
—
—
0
0
(4034850)
86
789
1.09
0.32
9.3
8.9
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
48
426
1.13
0.32
1.1
1.3
mmol/l
65.9
62.1
0.25
42
342
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
10
74
1.35
0.32
1.2
1.1
%
115.4
117.4
—
10
68
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
12
92
1.31
0.31
1.9
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
33
380
0.87
0.31
1.5
1.7
—
—
—
0
0
(4268621)
30
258
1.16
0.31
2.3
2.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
17
138
1.23
0.30
1.0
1.4
—
54.4
—
0
16
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
46
515
0.89
0.30
1.3
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
61
553
1.11
0.30
3.3
3.2
mg/l
1.6
1.5
0.37
51
515
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
243
2541
0.95
0.29
1.7
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
39
344
1.14
0.29
1.1
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
126
1343
0.94
0.29
1.7
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
31
269
1.15
0.29
1.2
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
8
106
0.75
0.29
13.1
12.2
nmol/l
825.6
871.8
—
8
100
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
317
1.14
0.28
1.1
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
18
149
1.21
0.27
1.1
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
47
422
1.12
0.27
1.3
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
42
375
1.12
0.27
1.3
1.2
u/ml
5.6
4.5
0.12
16
106
(3020891) Body temperature
79
854
0.92
0.27
4.3
4.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
8
65
1.23
0.27
1.1
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
338
3265
1.04
0.27
1.9
2.0
—
—
—
0
0
(44790048)
21
247
0.85
0.27
1.3
1.3
—
—
—
0
0
(44790047)
21
247
0.85
0.27
1.3
1.3
—
—
—
0
0
(44806118)
21
247
0.85
0.27
1.3
1.3
—
—
—
0
0
(44790049)
21
247
0.85
0.27
1.3
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
19
159
1.20
0.26
3.6
1.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
67
1.19
0.26
1.4
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
52
472
1.10
0.26
1.5
1.5
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
75
0.67
0.25
3.4
2.5
nmol/l
110.6
146.1
—
5
64
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
16
132
1.21
0.25
1.4
1.4
mmol/l
5.7
5.8
0.15
16
127
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
46
415
1.11
0.25
1.3
2.2
nmol/l
0.8
0.8
0.11
35
347
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
69
747
0.92
0.25
2.4
2.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
114
1.23
0.25
1.1
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
114
1.23
0.25
1.1
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
13
105
1.24
0.24
1.1
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
105
1.24
0.24
1.2
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
87
1.27
0.24
1.3
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
385
3743
1.03
0.23
1.8
1.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
39
1.28
0.23
2.0
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
107
1133
0.94
0.22
5.7
9.0
mmol/l
24.6
24.4
0.27
97
1070
(3043409) Potassium [Moles/volume] in Arterial blood
59
639
0.92
0.22
4.0
3.9
mmol/l
3.9
3.8
0.50
52
605
(3023511) Choriogonadotropin [Units/volume] in Urine
46
419
1.10
0.22
1.4
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
235
2265
1.04
0.22
2.1
2.1
g/l
0.2
0.2
0.89
222
2135
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
40
1.25
0.22
3.0
7.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
19
221
0.86
0.22
1.5
1.4
e6/l
56201.1
48026.5
0.06
12
121
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
28
248
1.13
0.21
2.2
2.4
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.3
—
0
6
(3011325) HIV 1+2 Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
11
0.00
0.21
0.0
7.7
—
155.5
—
0
6
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
10
0.00
0.21
0.0
5.1
—
365.2
—
0
10
(21494755) Public health laboratory ask at order entry panel
196
2038
0.96
0.21
1.2
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
135
1.19
0.21
1.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
0.9
—
0
7
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
61
657
0.93
0.21
1.9
1.7
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
43
1.16
0.21
1.2
1.3
—
—
—
0
0
(3013862) HLA-DP [Type]
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
1.4
—
0
7
(3017509) Phencyclidine [Presence] in Urine
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
56
604
0.93
0.20
1.1
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
136
1.18
0.20
1.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
49
1.22
0.20
1.0
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
49
1.22
0.20
1.0
1.3
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
12
144
0.83
0.19
1.4
1.3
u/l
9.0
10.9
0.50
12
134
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
103
977
1.06
0.19
1.8
1.7
g/l
1.5
1.6
0.26
88
841
(3014133) Dog dander IgE Ab [Units/volume] in Serum
27
302
0.89
0.19
1.0
1.0
u/ml
1.7
2.9
—
8
105
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
25
222
1.13
0.19
1.0
1.1
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
15
175
0.86
0.18
1.7
1.4
u/l
294.5
329.9
0.15
15
170
(40768446) Kidney Pathology biopsy report
10
81
1.24
0.18
1.2
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
27
301
0.90
0.18
1.2
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
48
444
1.08
0.18
1.5
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
58
1.21
0.18
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
59
1.19
0.18
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
52
484
1.08
0.17
1.8
2.3
g/l
130.7
126.6
0.53
40
339
(3006922) Hepatitis E virus Ab [Presence] in Serum
17
148
1.15
0.17
1.1
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
70
1.14
0.16
1.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
20
225
0.89
0.16
2.0
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
18
158
1.14
0.16
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
25
225
1.11
0.16
1.8
2.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
34
312
1.09
0.15
1.2
1.3
mmol/l
7.1
7.4
0.18
26
230
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
54
506
1.07
0.15
1.3
1.4
e6/l
8.5
31.7
1.48
43
377
(3000475) Leukocytes [#/volume] in Synovial fluid
62
584
1.06
0.15
1.7
1.6
e6/l
15205.2
10964.8
0.28
45
434
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
19
168
1.13
0.15
3.6
1.9
%
17.0
13.4
—
6
71
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
76
0.79
0.15
1.5
1.5
ug/l
8.4
9.0
—
6
76
(3033799) Differential panel - Peritoneal fluid
6
77
0.78
0.15
1.2
2.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
191
1852
1.03
0.15
1.6
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
121
1259
0.96
0.15
1.5
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
79
1.14
0.15
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
62
585
1.06
0.15
1.8
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
54
507
1.07
0.15
1.4
1.4
e6/l
1037.3
1278.7
0.12
47
400
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
140
1.14
0.15
1.1
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
35
323
1.08
0.14
1.8
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
453
4451
1.02
0.14
3.7
3.5
ng/l
192.0
339.1
0.50
316
3319
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
20
223
0.90
0.14
1.1
1.1
—
85.0
—
0
5
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
73
694
1.05
0.14
2.9
2.8
u/ml
0.3
0.4
0.62
48
389
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
21
189
1.11
0.13
1.2
1.1
—
—
—
0
0
(3000492) Spirometry study
226
2204
1.03
0.13
1.4
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
24
218
1.10
0.13
1.2
1.4
%
38.0
33.6
0.24
14
135
(3027456) Digoxin [Moles/volume] in Serum or Plasma
45
422
1.07
0.13
3.1
3.1
nmol/l
0.8
0.8
0.10
34
327
(3051651) Icteric interference index of Serum or Plasma
14
159
0.88
0.13
6.7
3.7
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
107
0.84
0.13
1.4
2.6
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
21
190
1.11
0.12
1.2
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
79
756
1.05
0.12
1.9
2.2
ug/l
245.7
769.2
1.11
70
706
(3006653) Thiamine [Moles/volume] in Blood
14
123
1.14
0.12
1.1
1.3
nmol/l
120.9
135.8
0.62
14
123
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
14
123
1.14
0.12
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
26
239
1.09
0.12
1.4
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
116
0.86
0.12
1.0
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
24
220
1.09
0.11
1.4
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
28
259
1.08
0.11
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
19
208
0.91
0.10
1.1
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
19
173
1.10
0.10
2.0
2.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
19
173
1.10
0.10
1.0
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2006
20133
0.99
0.10
17.7
16.3
%
13.6
13.7
1.51
1965
19709
(3023199) Leukocytes [#/volume] in Pleural fluid
23
249
0.92
0.10
1.4
1.5
e6/l
6041.2
2377.5
0.33
17
176
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
27
251
1.08
0.10
1.1
1.5
ug/l
1.9
4.1
1.22
21
208
(3051101) Glucose [Moles/volume] in Cord blood
5
44
1.14
0.10
6.2
6.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
47
447
1.05
0.10
1.5
1.3
—
17.6
—
0
10
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
135
0.89
0.09
1.1
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
46
1.09
0.09
3.0
6.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
87
1.15
0.09
1.1
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
1697
16898
1.01
0.09
3.8
3.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
164
1604
1.02
0.09
1.4
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
55
1.09
0.09
1.3
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
26
243
1.07
0.08
1.3
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
183
1866
0.98
0.08
3.3
2.7
ng/l
201.7
174.6
0.39
166
1699
(4015189)
5
61
0.82
0.08
4.0
2.3
—
—
—
0
0
(3035880) pH of Pleural fluid
13
117
1.11
0.08
1.4
1.4
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
7
65
1.08
0.08
1.4
3.7
—
163.7
—
0
26
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
70
0.86
0.07
1.3
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
215
0.93
0.07
1.5
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
74
1.08
0.07
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
408
0.96
0.07
1.1
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
12
108
1.11
0.07
1.6
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
52
539
0.96
0.07
1.3
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
88
1.02
0.07
1.4
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
46
478
0.96
0.06
1.5
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
96
982
0.98
0.06
4.2
3.9
mmol/l
24.6
24.2
0.45
84
891
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
46
477
0.96
0.06
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
46
477
0.96
0.06
1.5
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
19
203
0.94
0.06
1.5
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
12
109
1.10
0.06
1.3
2.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
634
6298
1.01
0.06
3.5
2.9
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
19
178
1.07
0.05
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
46
476
0.97
0.05
1.5
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
90
1.11
0.05
1.7
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
45
435
1.04
0.05
1.6
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
36
374
0.96
0.05
1.1
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
12
110
1.09
0.05
1.5
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
270
2726
0.99
0.05
1.7
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
34
353
0.96
0.04
1.1
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
20
189
1.06
0.04
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
20
189
1.06
0.04
1.2
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
110
1118
0.98
0.04
1.3
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
104
1057
0.98
0.04
1.5
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
18
170
1.06
0.04
1.7
1.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
20
190
1.05
0.04
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
20
190
1.05
0.04
1.2
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
21
200
1.05
0.03
1.0
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
21
200
1.05
0.03
1.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
121
1.07
0.03
1.1
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
16
169
0.95
0.03
3.3
2.1
%
11.1
10.7
0.14
16
169
(40768441) Liver Pathology biopsy report
18
189
0.95
0.03
1.2
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
112
1.07
0.03
1.8
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
122
1.07
0.02
1.1
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
25
259
0.96
0.02
4.8
3.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
27
279
0.97
0.02
1.0
1.1
u/ml
1.0
3.9
—
10
103
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
93
1.08
0.02
3.5
5.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
32
312
1.03
0.02
2.3
3.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
117
0.94
0.01
1.0
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
13
137
0.95
0.01
1.3
1.5
u/l
9.8
12.7
1.32
13
132
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
41
402
1.02
0.01
1.3
1.3
u/ml
104.2
123.4
0.51
11
80
(3025018) Bordetella pertussis Ab [Titer] in Serum
14
147
0.95
0.01
1.2
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
17
163
1.04
0.01
1.0
1.0
ng/l
328.1
351.5
0.21
12
112
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
124
1.05
0.00
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
13
124
1.05
0.00
1.3
1.7
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
24
234
1.03
0.00
1.4
1.3
e6/l
15851.2
61316.0
0.70
16
162
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
234
1.03
0.00
1.2
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
250
2494
1.00
0.00
1.6
1.7
%
1.4
1.4
0.17
219
2183
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
17
165
1.03
0.00
1.0
1.0
ng/l
693.6
729.5
0.13
12
110
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
24
241
1.00
0.00
1.5
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
30
301
1.00
0.00
1.1
1.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
13
126
1.03
0.00
1.0
1.0
u/l
1.3
1.1
—
6
69
(4027681)
13
134
0.97
0.00
1.2
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
38
384
0.99
0.00
1.0
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
13
132
0.98
0.00
1.2
1.0
u/ml
0.4
0.5
—
5
29
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
132
0.98
0.00
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
77
772
1.00
0.00
1.4
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
45
453
0.99
0.00
3.1
2.7
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
13
127
1.02
0.00
2.6
3.5
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
17
167
1.02
0.00
1.0
1.0
ng/l
47.1
47.8
0.03
12
114
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.3
—
0.0
—
0
7
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
74
0.95
0.00
1.0
1.3
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
14.4
—
0
7
(3042733) HLA Ab [Presence] in Serum
5
53
0.94
0.00
6.6
5.2
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
53
0.94
0.00
1.4
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
85
0.94
0.00
1.0
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
92
0.98
0.00
1.2
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
59
1.02
0.00
1.0
1.3
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
73
0.96
0.00
1.0
2.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
88
0.91
0.00
2.8
2.8
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
91
910
1.00
0.00
3.0
3.4
u/ml
214.7
2109.5
0.98
71
771
(3026250) Tacrolimus [Mass/volume] in Blood
8
79
1.01
0.00
36.6
31.8
ug/l
7.3
7.4
—
8
72
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
198.8
—
0
6
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
32.4
—
0
5
(3018738) Hemoglobin F/Hemoglobin.total in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
14
140
1.00
0.00
2.6
3.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
70
1.00
0.00
1.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
3.9
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_GOITRENOD and mortality.

Females

Parameter HR [95% CI] p-value
E4_GOITRENOD 0.933 [0.84, 1.03] 0.168
Birth year 0.994 [0.99, 1.0] 0.161

During the follow-up period (1.1.1998 — 31.12.2019), 978 out of 10026 females with E4_GOITRENOD died.

Males

Parameter HR [95% CI] p-value
E4_GOITRENOD 0.863 [0.76, 0.98] 0.019
Birth year 0.993 [0.98, 1.0] 0.145

During the follow-up period (1.1.1998 — 31.12.2019), 395 out of 2426 males with E4_GOITRENOD died.

Mortality risk

Mortality risk for people of age

years, who have E4_GOITRENOD.

N-year risk Females Males
1 0.064% 0.205%
5 0.56% 1.157%
10 1.27% 3.068%
15 2.514% 5.741%
20 4.303% 10.132%

Relationships between endpoints

↥

Index endpoint: E4_GOITRENOD – Nontoxic single thyroid nodule

GWS hits: 5

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data